ArticleIn vivo (Athens, Greece)

Assessment of Time-to-onset and Outcome of Lung Adverse Events With Pomalidomide from a Pharmacovigilance Study.

Yuka Kawahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.